Post Profile






EMA committee conditionally approves AbbVie leukemia drug

(Reuters) - AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency (EMA) on Friday for a drug to treat a form of blood cancer.
read more

share

Related Posts


EMA Lifts Conditional Status For GSK's Votrient® (Pazopanib) And Grants Full Approval

Health : Medical News Today

GlaxoSmithKline (GSK) has announced that the European Medicines Agency (EMA) has agreed to remove the conditional status of the marketing authorisation for Votrient (pazopanib) and convert it to a full marketing authorisation. Pazop...

FDA Approves New Drug For Rare Blood Cancer

Health : Time: Healthland

(WASHINGTON) — The Food and Drug Administration has approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer. The agency says it approved Imbruvica for patients with mantle ...

New Study Finds FDA Approval Process For Cancer Drugs Faster Than The European Medicines Agency (EMA)

Health : Medical News Today

The US Food and Drug Administration (FDA) is often criticized as inefficient compared to its European counterpart, the European Medicines Agency (EMA), particularly in the field of oncology. However, a new study appearing in Health ...

EMA panel recommends nod for Pfizer's breast cancer drug

Health : Reuters: Health

(Reuters) - U.S. drugmaker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.

Intercept's liver drug gets conditional backing of EMA panel

Health : Reuters: Health

(Reuters) - Drugmaker Intercept Pharmaceuticals Inc's drug to treat a rare liver condition was conditionally approved an advisory committee to the European Medicines Agency on Friday.

Comments


Copyright © 2016 Regator, LLC